These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16989264)

  • 21. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
    Zoppi G; Trucchi C
    J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rationale for population-based surveillance for Haemophilus influenzae type b meningitis.
    Levine OS; Schwartz B
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S195-8. PubMed ID: 9781762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass vaccination: when and why.
    Heymann DL; Aylward RB
    Curr Top Microbiol Immunol; 2006; 304():1-16. PubMed ID: 16989261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1022-4. PubMed ID: 23254256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
    Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
    Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expanded programme on immunization: a lasting legacy of smallpox eradication.
    Okwo-Bele JM; Cherian T
    Vaccine; 2011 Dec; 29 Suppl 4():D74-9. PubMed ID: 22486980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002.
    Watt JP; Levine OS; Santosham M
    J Pediatr; 2003 Dec; 143(6 Suppl):S163-87. PubMed ID: 14657805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of the national polio immunization campaign on levels and equity in immunization coverage: evidence from rural North India.
    Bonu S; Rani M; Baker TD
    Soc Sci Med; 2003 Nov; 57(10):1807-19. PubMed ID: 14499507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
    Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
    Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
    Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
    Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putting safety first: ensuring safe vaccination practices during the 2006 rubella campaign in Bolivia.
    Halkyer P; Azurduy R; Fuentes M; Van Dick AM; Ronveaux O
    J Infect Dis; 2011 Sep; 204 Suppl 2():S718-21. PubMed ID: 21954272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine strategies: Optimising outcomes.
    Hardt K; Bonanni P; King S; Santos JI; El-Hodhod M; Zimet GD; Preiss S
    Vaccine; 2016 Dec; 34(52):6691-6699. PubMed ID: 27887796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
    Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
    Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
    Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Andean region: measles on the way out.
    EPI Newsl; 1996 Oct; 18(5):1-3. PubMed ID: 12320547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of routine and campaign vaccination strategies in Ecuador.
    Shepard DS; Robertson RL; Cameron CS; Saturno P; Pollack M; Manceau J; Martínez P; Meissner P; Perrone J
    Bull World Health Organ; 1989; 67(6):649-62. PubMed ID: 2517411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.